Artículos
Potential of incretin-based therapies for non-alcoholic fatty liver disease.
Autores: Samson SL, Bajaj M.
Improved glycaemia correlates with liver fat reduction in obese, type 2 diabetes, patients given glucagon-like peptide-1 (GLP-1) receptor agonists.
Autores: Cuthbertson DJ, Irwin A, Gardner CJ, Daousi C, Purewal T, Furlong N, Goenka N, Thomas EL, Adams VL, Pushpakom SP, Pirmohamed M, Kemp GJ.
Insulin Degludec Once-Daily in Type 2 Diabetes: Simple or Step-Wise Titration (BEGIN: Once Simple Use).
Autores: Philis-Tsimikas A, Brod M, Niemeyer M, Ocampo Francisco AM, Rothman J.
Experience over 12 years with home enteral nutrition in a healthcare area of Spain.
Autores: De Luis DA, Izaola O, Cuellar LA, Terroba MC, Cabezas G, De La Fuente B.
A randomized clinical trial with two doses of an enteral diabetes-specific suplements in elderly patients with diabetes mellitus type 2.
Autores: de Luis DA, Izaola O, de la Fuente B, Terroba MC, Cuellar L, Cabezas G.
BLOOD GLUCOSE AND INSULIN RESPONSES TO TWO HYPOCALORIC ENTERAL FORMULAS IN PATIENTS WITH DIABETES MELLITUS TYPE 2.
Autores: de Luis DA, Izaola O, de la Fuente B, Araújo K.
Genetic variation in the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) and their influence on weight loss and insulin resistance under a high monounsaturated fat hypocaloric diet.
Autores: de Luis D, Aller R, Izaola O, Conde R, de la Fuente B, Sagrado MG.
Serum visfatin levels and metabolic syndrome criteria in obese female subjects.
Autores: de Luis DA, Aller R, Gonzalez Sagrado M, Conde R, Izaola O, de la Fuente B.
A randomized clinical trial with two doses of a omega 3 fatty acids oral and arginine enhanced formula in clinical and biochemical parameters of head and neck cancer ambulatory patients.
Autores: de Luis DA, Izaola O, Cuellar L, Terroba MC, de la Fuente B, Cabezas G.
Experience over 12 years with home enteral nutrition in a healthcare area of Spain.
Autores: De Luis DA, Izaola O, Cuellar LA, Terroba MC, Cabezas G, De La Fuente B.